Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma.

Grossmann, V; Bacher, U; Artusi, V; Kohlmann, A; Nadarajah, N; Kern, W; Schnittger, S; Haferlach, T; Haferlach, C

Grossmann, V; Bacher, U; Artusi, V; Kohlmann, A; Nadarajah, N; Kern, W; Schnittger, S; Haferlach, T; Haferlach, C.

Affiliation

Grossmann V; MLL Munich Leukemia Laboratory GmbH, Munich, Germany.

Blood Cancer J ; 2: e85, 2012 Aug 31.

Article in En | MEDLINE | ID: mdl-22941340

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432486
https://dx.doi.org/10.1038/bcj.2012.33

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Cancer J Year: 2012 Document type: Article Affiliation country:

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432486
https://dx.doi.org/10.1038/bcj.2012.33

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Cancer J Year: 2012 Document type: Article Affiliation country: